NeuroMetrix, Inc.

Fibromyalgia affects millions of people with debilitating symptoms that can affect their quality of life on a daily basis. Today, on Fibromyalgia Awareness Day, please join us as we raise awareness and support those living with this complex and often misunderstood health condition. To learn more about how Quell Fibromyalgia helps reduce symptoms in patients with fibromyalgia and high pain sensitivity visit our website: https://bit.ly/44Ug2BP #NeuroMetrix #QuellFibromyalgia #fibromyalgia #FibromyalgiaAwarenessDay

Did you know that since January 2023, DPNCheck has been featured in no fewer than twelve peer-reviewed publications? See the rapidly growing body of research that investigates or leverages our easy-to-use handheld nerve conduction test here: https://bit.ly/3vs7VPo Interested in using DPNCheck measurements in your own research? Learn more about the advantages of using DPNCheck in clinical trials: https://bit.ly/4cv0QOK #ClinicalResearch #ClinicalTrials #Diabetes #DiabetesResearch #PeripheralNeuropathy

Hayashi et al recently published findings in The Journal of Diabetes Investigation demonstrating that DPNCheck's point-of-care nerve conduction study could accurately predict the severity of peripheral neuropathy in patients with diabetes (DPN). “The use of DPNCheck and electrocardiogram would make the diagnosis of DPN simple, ubiquitous, and with high reproducibility and reliability.” (read more) #Diabetes #DiabetesCare #DiabetesManagement #PeripheralNeuropathy #DPN #NCS #Neurology

And that's a wrap! Thank you RISE for a fantastic conference. So happy to connect with friends and colleagues at one the best gatherings of the year. Special thanks to John Romans of Biomedix and Dr. Shannon I. Decker, PhD., MBA, MBA, M.Ed., M.Ed. for sharing their insights and expertise to help drive better patient outcomes. #RISENational2024

PRESS RELEASE: NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy https://bit.ly/3PqgOzJ "The use of DPNCheck and electrocardiogram would make the diagnosis of DPN simple, ubiquitous, and with high reproducibility and reliability." - Hayashi et al “The consistently high accuracy of DPNCheck stands in stark contrast to monofilament testing, which has been the standard approach to DPN screening despite its low accuracy and reliability” - Shai Gozani, CEO NeuroMetrix, Inc. #Diabetes #DiabetesCare #DiabetesManagement #PeripheralNeuropathy #DPN #NCS #Neurology

Headed to RISE National in Nashville this weekend? NeuroMetrix, Inc. will be there! Connect with Brandi Damkier, our very own VP of Clinical Partnerships. Learn how a simple DPNCheck test at the point of care can help healthcare providers detect and defend against some of the most dangerous complications of #Diabetes. https://bit.ly/4cfBT9L #EarlyDetection #RiseNational2024 #ValueBasedCare #DiabetesCare #PeripheralNeuropathy #Nephropathy #Retinopathy #CKD #medicareadvantage

Fibromyalgia occurs in up to 40% of patients with rheumatic conditions*. Are you treating it? Stop by our booth at the State of Texas Association of Rheumatologists (STAR) Annual Meeting to learn more about Quell Fibromyalgia – the first and only FDA authorized medical device that helps reduce the symptoms of #fibromyalgia. * Pincus T, et al. THU0328 Secondary Fibromyalgia in Patients with Other Rheumatic Diagnoses: Clues for Recognition on a Multidimensional Health Assessment Questionnaire (MDHAQ) and Physician Rheumatic Checklist. Annals of the Rheumatic Diseases 2015;74:314. NeuroMetrix, Inc. | Breck Harmel | Nick Vanchina

We are honored and thrilled to attend the American Diabetes Association’s Clinical Update Conference February 2-4. It’s not too late to register and join us: https://bit.ly/3SEGuuo As the number of people diagnosed with diabetes has nearly quadrupled since 1980, and as advances in care result in more seniors with diabetes or prediabetes, it becomes even more important to understand how we can enable earlier detection of comorbidities. If you’ll be there, please keep an eye out for Susan Bell RN, BN, NeuroMetrix, Inc. SVP of Population Health and Value Based Care. She’s eager to learn and connect, and we’re eager to share her impressions and messages as the ADA and its esteemed experts present their recently released Standards of Care for 2024. #ADAClinicalUpdate #Diabetes #DiabetesCare #DiabetesManagement #ValueBasedCare #MedicareAdvantage #PeripheralNeuropathy #DetectPeripheralNeuropathy #diabeteseducation #primarycare